Pneumonia III: Complications and Assessment
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure III: Clinical Manifestations
Acute Respiratory Failure-II
Factors Affecting the Risk of Infection
Pneumonia II: Pathophysiology
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 21, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Emad Nader Eskandar1, David J Altschul2, Rafael de la Garza Ramos1
1From the Departments of Neurological Surgery (E.N.E., D.J.A., R.d.l.G.R., P.C., S.R.U., J. Benton, J.D., A.T., J.F.-T., J.L., R.H., E.B.), Neurology (N.P., A. Malaviya, D.F., D.A., D.L., J.G., V.F., J.R., C.E., M.M., A.B., M.F.M.), Radiology (R.Z., K.H., A. McClelland, J. Burns, A.E.), and Critical Care Medicine (R.M., M.G.), Albert Einstein College of Medicine, Montefiore Medical Center (P.S., V.F., J.R.), Bronx, NY.
Neurologic syndromes in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increase the risk of inpatient mortality. Identifying and treating altered mentation or stroke in COVID-19 patients may reduce mortality.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: